Finance

Lists
600529:SHA
Shandong Pharmaceutical Glass Co Ltd
CNÂ¥19.17
+0.42%
(+0.080) 1D
Aug 28, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600529...
Open
CNÂ¥19.05
High
CNÂ¥19.19
Low
CNÂ¥19.04
Mkt. cap
12.72B
Avg. vol.
11.61M
Volume
4.03M
Dividend
2.40%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 20, 2026
P/E ratio
18.45
52-wk high
CNÂ¥22.60
52-wk low
CNÂ¥17.30
EPS
CNÂ¥1.04
Shares outstanding
424.98M
No. of employees
7K
Open
CNÂ¥19.05
High
CNÂ¥19.19
Low
CNÂ¥19.04
Mkt. cap
12.72B
Avg. vol.
11.61M
Volume
4.03M
Dividend
2.40%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 20, 2026
P/E ratio
18.45
52-wk high
CNÂ¥22.60
52-wk low
CNÂ¥17.30
EPS
CNÂ¥1.04
Shares outstanding
424.98M
No. of employees
7K
About Shandong Pharmaceutical Glass Co Ltd
CEO-
Employees6.78K
Founded1970
Headquarters-
SectorMedical device
Websitepharmglass.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.03B
1.07B
1.22B
1.06B
Cost of goods sold
603.35M
812.53M
822.10M
708.81M
Cost of revenue
603.35M
812.53M
822.10M
708.81M
Research and development expenses
42.82M
36.30M
36.72M
38.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.38M
66.76M
80.66M
85.99M
Operating expense
137.74M
121.26M
138.76M
124.12M
Total operating expenses
741.09M
933.79M
960.86M
832.93M
Operating income
285.58M
139.71M
258.21M
228.40M
Other non operating income
3.13M
-5.22M
-8.26M
-8.60M
EBT including unusual items
206.84M
182.44M
239.23M
213.13M
EBT excluding unusual items
289.83M
146.33M
257.77M
221.56M
Income tax expense
35.53M
35.26M
38.02M
43.46M
Effective tax rate
17.18%
19.33%
15.89%
20.39%
Other operating expenses
-169.23K
22.86M
10.75M
10.50M
Net income
171.31M
147.17M
201.21M
169.66M
Net profit margin
16.69%
13.71%
16.50%
15.99%
Earnings per share
0.25
0.21
0.29
0.24
Interest and investment income
9.95M
8.05M
8.53M
1.76M
Interest expense
-7.06K
-495.98K
-706.06K
-
Net interest expenses
9.94M
7.56M
7.83M
1.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
381.78M
237.03M
355.52M
322.92M
Gain or loss from assets sale
417.48K
-1.45M
-
-2.50M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps